Breaking the Balance: Baseline Oxidative Stress and DNA Repair Capacity in Multiple Myeloma Therapy
Cancers · 19.06.2026 · 18 (12) · 1995
DOI: 10.3390/cancers18121995 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 19.06.2026. Verfasst von Panagiotis Malamos und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Biology, National Hellenic Research Foundation, 116 35 Athens, Greece. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union.
Abstract (Originalsprache)
Background/Objectives: Disruption of cellular redox balance and DNA damage response (DDR) signals represents a key driver of cancer development, influencing tumor progression and therapeutic response. Here, we investigated the interplay between DDR-related parameters and oxidative stress in relation to treatment response in patients with multiple myeloma (MM).
Methods
Oxidative stress and DDR signals were evaluated in primary cells, including peripheral blood mononuclear cells (PBMCs) and bone marrow plasma cells (BMPCs), collected at diagnosis from MM patients who were subsequently classified as responders (n = 35) or non-responders (n = 41) to melphalan-based therapy.
Results
PBMCs and BMPCs from non-responders exhibited a distinct biological profile characterized by lower baseline DNA damage, reduced oxidative stress, increased nucleotide excision repair and double-strand break repair capacity, and reduced apoptotic sensitivity compared with responders (all p < 0.001). In addition, non-responders displayed increased chromatin relaxation. Differential gene expression patterns involving DDR-related pathways further distinguished BMPCs between the two clinical outcome groups.
Conclusions
Collectively, these findings indicate that alterations in oxidative stress and DDR signals play a crucial role in determining response to melphalan-based therapy in MM. The identification of these molecular alterations in an easily accessible tissue, such as peripheral blood, underscores their potential clinical relevance and warrants further validation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Chemical Biology, National Hellenic Research Foundation, 116 35 Athens, Greece.
- Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, 176 76 Athens, Greece.
- Department of Clinical Therapeutics, National and Kapodistrian University of Athens, 115 28 Athens, Greece.
ORCID-Profile: Panagiotis Malamos, Konstantinos Voutetakis, Konstantinos Koutoulogenis, Olga Papadodima, Evangelos Terpos, Vassilis L Souliotis
Förderung
- European Union
Zitieren
APA
Malamos, P., Deligianni, E., Voutetakis, K., Koutoulogenis, K., Papadodima, O., Terpos, E., & Souliotis, V. L. (2026). Breaking the Balance: Baseline Oxidative Stress and DNA Repair Capacity in Multiple Myeloma Therapy. Cancers, 18(12), 1995. https://doi.org/10.3390/cancers18121995
Vancouver
Malamos P, Deligianni E, Voutetakis K, Koutoulogenis K, Papadodima O, Terpos E, et al. Breaking the Balance: Baseline Oxidative Stress and DNA Repair Capacity in Multiple Myeloma Therapy. Cancers. 2026;18(12):1995. doi:10.3390/cancers18121995
BibTeX
@article{Malamos2026,
author = {Malamos, Panagiotis and Deligianni, Elisavet and Voutetakis, Konstantinos and Koutoulogenis, Konstantinos and Papadodima, Olga and Terpos, Evangelos and Souliotis, Vassilis L},
title = {Breaking the Balance: Baseline Oxidative Stress and DNA Repair Capacity in Multiple Myeloma Therapy},
journal = {Cancers},
year = {2026},
volume = {18},
number = {12},
pages = {1995},
doi = {10.3390/cancers18121995}
}
EUVIMED